Home  |  Contact

Cellosaurus MOR/0.4R (CVCL_2619)

[Text version]
Cell line name MOR/0.4R
Accession CVCL_2619
Resource Identification Initiative To cite this cell line use: MOR/0.4R (RRID:CVCL_2619)
Comments Population: Caucasian.
Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
Derived from site: In situ; Lung; UBERON=UBERON_0002048.
Disease Lung adenocarcinoma (NCIt: C3512)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_2618 (MOR)
Sex of cell Sex unspecified
Age at sampling Age unspecified
Category Cancer cell line
STR profile Source(s): ECACC

Markers:
AmelogeninX
CSF1PO10
D5S81812
D7S8209
D13S31712
D16S5399
TH017
TPOX11
vWA15

Run an STR similarity search on this cell line
Publications

PubMed=7903701; DOI=10.1093/jnci/86.2.110
Barrand M.A., Heppell-Parton A.C., Wright K.A., Rabbitts P.H., Twentyman P.R.
A 190-kilodalton protein overexpressed in non-P-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP gene.
J. Natl. Cancer Inst. 86:110-117(1994)

Cross-references
Cell line collections (Providers) ECACC; 96042334
Cell line databases/resources CLO; CLO_0007834
Encyclopedic resources Wikidata; Q54906390
Entry history
Entry creation04-Apr-2012
Last entry update29-Jun-2023
Version number11